Name: XRTX Cash And Cash Equivalents 2018-2021
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

XORTX Therapeutics Inc. Cash And Cash Equivalents

XORTX Therapeutics Inc. (XRTX) had Cash And Cash Equivalents of CAD 18.85 million as of 2021-12-31, per its 20-F filed 2022-05-03.

Discontinued › Notes

ifrs-full:CashAndCashEquivalents · last filed 2022-05-03

2021-12-31: Cash And Cash Equivalents 18.85M CAD.
2020-12-31: Cash And Cash Equivalents 171.27K CAD.
2019-12-31: Cash And Cash Equivalents 58.61K CAD.
2018-12-31: Cash And Cash Equivalents 260.02K CAD.

Period end	Cash And Cash Equivalents
2021-12-31	18.85M CAD 20-F · filed 2022-05-03
2020-12-31	171.27K CAD 20-F · filed 2022-05-03
2019-12-31	58.61K CAD 20-F · filed 2022-05-03
2018-12-31	260.02K CAD 20-F · filed 2022-05-03